首页> 外文OA文献 >Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

【2h】

Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

机译：创新策略在自体造血干细胞移植后新型诱导治疗的多发性骨髓瘤患者中的植入综合征最小化

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Gonzalo Gutiérrez-García; Montserrat Rovira; Laura Magnano; Laura Rosiñol; Alex Bataller; María Suárez-Lledó; María Teresa Cibeira; Carlos Fernández de Larrea; Marta Garrote; Sofia Jorge; Ana Moreno; Luis Gerardo Rodríguez-Lobato; Enric Carreras; Maribel Díaz-Ricart; Marta Palomo; Carmen Martínez; Alvaro Urbano-Ispizua; Joan Bladé; Francesc Fernández-Avilés;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation [J] . Gutierrez-Garcia Gonzalo, Rovira Montserrat, Magnano Laura, Bone marrow transplantation . 2018,第12期

机译：创新策略在自体造血干细胞移植后新型诱导治疗的多发性骨髓瘤患者中的植入综合征最小化
2. Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients [J] . Philip L. McCarthy, Theresa Hahn Hematology . 2013,第1期

机译：适于移植的多发性骨髓瘤患者的诱导，自体造血干细胞移植，合并和维持的策略
3. Procalcitonin as a biomarker to differentiate bacterial infections from engraftment syndrome following autologous hematopoietic stem cell transplantation for multiple myeloma [J] . Knoll Bettina M., Ahmed Jibran, Karass Michael, American Journal of Hematology . 2019,第3期

机译：ProCalcitonin作为一种生物标志物，以在多发性骨髓瘤的自体造血干细胞移植后将细菌感染分解植入综合征
4. HIGH DOSE THERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR PATIENTS WITH PRIMARY SYSTEMIC AMYLOIDOSIS (AL): AN ABMTR STUDY [C] . DH Vesole, W Perez, D Reece, International Symposium on Amyloidosis . 2005

机译：具有自体造血干细胞移植（HSCT）的高剂量治疗用于初级全身淀粉样蛋白症（AL）的患者：ABMTR研究
5. Posttraumatic stress disorder and sub-syndromal trauma symptoms in cancer patients treated with autologous hematopoietic stem cell transplant and standard dose chemotherapy. [D] . Gourvitz, Ross L. 2008

机译：自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
6. CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation [O] . Elifcan ALADAĞ, Haluk DEMİROĞLU, Yahya BÜYÜKAŞIK, 2020

机译：CD34 +造血祖细胞剂量作为植入和存活的多发性骨髓瘤患者的预测因子经历自体干细胞移植
7. Strategies for induction, autologous hematopoietic stem cell transplantation, consolidation, and maintenance for transplantation-eligible multiple myeloma patients [O] . Philip L. McCarthy, Theresa Hahn 2013

机译：诱导，自体造血干细胞移植，固结和维持移植符合条件多发性骨髓瘤患者的策略

Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation

著录项

相似文献

相关主题

期刊订阅